These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23071935)

  • 1. Solubility of aceclofenac in polyamidoamine dendrimer solutions.
    Patel J; Garala K; Basu B; Raval M; Dharamsi A
    Int J Pharm Investig; 2011 Jul; 1(3):135-8. PubMed ID: 23071935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
    Yiyun C; Tongwen X
    Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamidoamine Starburst dendrimers as solubility enhancers.
    Milhem OM; Myles C; McKeown NB; Attwood D; D'Emanuele A
    Int J Pharm; 2000 Mar; 197(1-2):239-41. PubMed ID: 10704811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
    Yiyun C; Tongwen X; Rongqiang F
    Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
    Yiyun C; Tongwen X
    Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine.
    Devarakonda B; Hill RA; de Villiers MM
    Int J Pharm; 2004 Oct; 284(1-2):133-40. PubMed ID: 15454304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
    Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
    Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
    Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAMAM dendrimers for the delivery of the antibacterial Triclosan.
    Gardiner J; Freeman S; Leach M; Green A; Alcock J; D'Emanuele A
    J Enzyme Inhib Med Chem; 2008 Oct; 23(5):623-8. PubMed ID: 18821252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5-fluorouracil in aqueous solutions.
    Buczkowski A; Waliszewski D; Urbaniak P; Palecz B
    Int J Pharm; 2016 May; 505(1-2):1-13. PubMed ID: 27039147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
    Madaan K; Lather V; Pandita D
    Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged drug delivery system of an antifungal drug by association with polyamidoamine dendrimers.
    Jose J; Charyulu RN
    Int J Pharm Investig; 2016; 6(2):123-7. PubMed ID: 27051632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.
    Devarakonda B; Hill RA; Liebenberg W; Brits M; de Villiers MM
    Int J Pharm; 2005 Nov; 304(1-2):193-209. PubMed ID: 16198076
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Nazlı H; Gedik G
    Pharm Dev Technol; 2021 Sep; 26(7):750-764. PubMed ID: 34154500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility enhancement of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers.
    Koç FE; Senel M
    Int J Pharm; 2013 Jul; 451(1-2):18-22. PubMed ID: 23628406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Polyamidoamine Dendrimer for Encapsulating Tetramethylscutellarein for Potential Bioactivity Enhancement.
    Shadrack DM; Mubofu EB; Nyandoro SS
    Int J Mol Sci; 2015 Nov; 16(11):26363-77. PubMed ID: 26556337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
    Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
    Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.
    Devarakonda B; Otto DP; Judefeind A; Hill RA; de Villiers MM
    Int J Pharm; 2007 Dec; 345(1-2):142-53. PubMed ID: 17600643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity.
    Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y
    Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamidoamine Dendrimers for Enhanced Solubility of Small Molecules and Other Desirable Properties for Site Specific Delivery: Insights from Experimental and Computational Studies.
    Shadrack DM; Swai HS; Munissi JJE; Mubofu EB; Nyandoro SS
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29895742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.